HCV

Medicaid hepatitis C virus treatment policies: impact on testing and treatment in the commercially insured
abstract Introduction A total of 23 state Medicaid programs continue to restrict hepatitis C virus (HCV) medication access by liver disease or substance-use criteria, creating obstacles to HCV elimination and significant care disparities.
Rachel L Epstein, Jianing Wang, Laura F White, Shashi N Kapadia, Jake R Morgan, Yuhua Bao, Benjamin P Linas
Cite Link
Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study
abstract Background The opioid epidemic has been associated with an increase in hepatitis C virus (HCV) infections. Federally qualified health centers (FQHCs) have a high burden of hepatitis C disease and could serve as venues to enhance testing and treatment.
Sabrina A Assoumou, Shayla Nolen, Liesl Hagan, Jianing Wang, Golnaz Eftekhari Yazdi, William W Thompson, Kenneth H Mayer, Jon Puro, Lin Zhu, Joshua A Salomon, Benjamin P Linas
Cite Link
Rapid versus laboratory-based testing for HIV and hepatitis C at a drug detoxification treatment center: a randomized trial
abstract Background A health department survey revealed nearly half employ laboratory-based HIV and HCV testing (LBT) over rapid testing (RT) in nonhospital settings such as drug detoxification centers. LBT has higher sensitivity for acute HIV infection compared to RT but LBT is not point of care and may result in fewer diagnoses due to loss to follow-up before result delivery.
Sabrina A Assoumou, Samantha M Paniagua, Benjamin P Linas, Jianing Wang, Jeffrey H Samet, Jonathan Hall, Laura F White, Curt G Beckwith
Cite DOI Link
HCV testing and treatment in a national sample of US federally qualified health centers during the opioid epidemic
abstract Background Federally qualified health centers (FQHCs) serve diverse communities in the United States (U.S.) and could function as important venues to diagnose and treat hepatitis C virus (HCV) infections.
Sabrina A Assoumou, Jianing Wang, Shayla Nolen, Golnaz Eftekhari Yazdi, Kenneth H Mayer, Jon Puro, Joshua A Salomon, Benjamin P Linas
Cite Link
Cost-effectiveness and budgetary impact of hepatitis C virus testing, treatment, and linkage to care in US prisons
abstract Background Hepatitis C virus (HCV) testing and treatment uptake in prisons remains low. We aimed to estimate clinical outcomes, cost-effectiveness (CE), and budgetary impact (BI) of HCV testing and treatment in United States (US) prisons or linkage to care at release.
Sabrina A Assoumou, Abriana Tasillo, Claudia Vellozzi, Golnaz Eftekhari Yazdi, Jianing Wang, Shayla Nolen, Liesl Hagan, William Thompson, Liisa M Randall, Lara Strick, Joshua A Salomon, Benjamin P Linas
Cite DOI Link
Hepatitis C virus antibody testing among 13-to 21-year-olds in a large sample of US federally qualified health centers
abstract Hepatitis C virus (HCV) incidence is increasing in the United States, with most new transmissions occurring among people younger than 30 years who inject drugs. Fifteen- to 24-year-olds represent an increasing proportion of reported chronic HCV infections, rising from 3.
Rachel L Epstein, Jianing Wang, Liesl Hagan, Kenneth H Mayer, Jon Puro, Benjamin P Linas, Sabrina A Assoumou
Cite DOI Link
Hepatitis C testing and patient characteristics in Washington State's prisons between 2012 and 2016
abstract Introduction: There is no widely accepted testing approach for hepatitis C virus infection in correctional settings, and many U.S. prisons do not provide routine testing. The aim of this study was to determine the most effective hepatitis C virus testing strategy in one U.
Sabrina A Assoumou, Jianing Wang, Abriana Tasillo, Golnaz Eftekhari Yazdi, Judith I Tsui, Lara Strick, Benjamin P Linas
Cite DOI Link
Population-level outcomes and cost-effectiveness of expanding the recommendation for age-based hepatitis C testing in the United States
abstract Background The US Centers for Disease Control and Prevention and the U.S. Preventive Services Task Force recommend one-time hepatitis C virus (HCV) testing for persons born 1945–1965 and targeted testing for high-risk persons.
Joshua A Barocas, Abriana Tasillo, Golnaz Eftekhari Yazdi, Jianing Wang, Claudia Vellozzi, Susan Hariri, Cheryl Isenhour, Liisa Randall, John W Ward, Jonathan Mermin, Joshua A Salomon, enjamin P Linas
Cite DOI Link